Literature DB >> 34147616

Diterpene glycosides from Holothuria scabra exert the α-synuclein degradation and neuroprotection against α-synuclein-Mediated neurodegeneration in C. elegans model.

Pawanrat Chalorak1, Nilubon Sornkaew2, Preeyanuch Manohong3, Nakorn Niamnont4, Nawaphat Malaiwong5, Tanapol Limboonreung6, Prasert Sobhon7, Michael Aschner8, Krai Meemon9.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Holothuria (Metriatyla) scabra Jaeger (H. scabra), sea cucumber, is the marine organism that has been used as traditional food and medicine to gain the health benefits since ancient time. Although our recent studies have shown that crude extracts from H. scabra exhibited neuroprotective effects against Parkinson's disease (PD), the underlying mechanisms and bioactive compounds are still unknown. AIM OF THE STUDY: In the present study, we examined the efficacy of purified compounds from H. scabra and their underlying mechanism on α-synuclein degradation and neuroprotection against α-synuclein-mediated neurodegeneration in a transgenic Caenorhabditis elegans PD model.
MATERIAL AND METHODS: The H. scabra compounds (HSEA-P1 and P2) were purified and examined for their toxicity and optimal dose-range by food-clearance and lifespan assays. The α-synuclein degradation and neuroprotection against α-synuclein-mediated neurodegeneration were determined using transgenic C. elegans model, Punc-54::α-syn and Pdat-1:: α-syn; Pdat-1::GFP, respectively, and then further investigated by determining the behavioral assays including locomotion rate, basal slowing rate, ethanol avoidance, and area-restricted searching. The underlying mechanisms related to autophagy were clarified by quantitative PCR and RNAi experiments.
RESULTS: Our results showed that HSEA-P1 and HSEA-P2 significantly diminished α-synuclein accumulation, improved motility deficits, and recovered the shortened lifespan. Moreover, HSEA-P1 and HSEA-P2 significantly protected dopaminergic neurons from α-synuclein toxicity and alleviated dopamine-associated behavioral deficits, i.e., basal slowing, ethanol avoidance, and area-restricted searching. HSEA-P1 and HSEA-P2 also up-regulated autophagy-related genes, including beclin-1/bec-1, lc-3/lgg-1, and atg-7/atg-7. RNA interference (RNAi) of these genes in transgenic α-synuclein worms confirmed that lc-3/lgg-1 and atg-7/atg-7 were required for α-synuclein degradation and DAergic neuroprotection activities of HSEA-P1 and HSEA-P2. NMR and mass spectrometry analysis revealed that the HSEA-P1 and HSEA-P2 contained diterpene glycosides.
CONCLUSION: These findings indicate that diterpene glycosides extracted from H. scabra decreases α-synuclein accumulation and protects α-synuclein-mediated DAergic neuronal loss and its toxicities via lgg-1 and atg-7.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Caenorhabditis elegans; Diterpene glycoside; Dopaminergic neuron; Holothuria scabra; Parkinson's disease; α-synuclein

Mesh:

Substances:

Year:  2021        PMID: 34147616      PMCID: PMC8381228          DOI: 10.1016/j.jep.2021.114347

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   5.195


  59 in total

1.  Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy.

Authors:  Ana Maria Cuervo; Leonidas Stefanis; Ross Fredenburg; Peter T Lansbury; David Sulzer
Journal:  Science       Date:  2004-08-27       Impact factor: 47.728

2.  Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease.

Authors:  Li Chen; Mel B Feany
Journal:  Nat Neurosci       Date:  2005-04-17       Impact factor: 24.884

3.  C. elegans locomotory rate is modulated by the environment through a dopaminergic pathway and by experience through a serotonergic pathway.

Authors:  E R Sawin; R Ranganathan; H R Horvitz
Journal:  Neuron       Date:  2000-06       Impact factor: 17.173

4.  Functional analysis of VPS41-mediated neuroprotection in Caenorhabditis elegans and mammalian models of Parkinson's disease.

Authors:  Adam J Harrington; Talene A Yacoubian; Sunny R Slone; Kim A Caldwell; Guy A Caldwell
Journal:  J Neurosci       Date:  2012-02-08       Impact factor: 6.167

Review 5.  Parkinson's disease: mechanisms and models.

Authors:  William Dauer; Serge Przedborski
Journal:  Neuron       Date:  2003-09-11       Impact factor: 17.173

6.  In vivo and in vitro biosynthesis of saponins in sea cucumbers.

Authors:  R G Kerr; Z Chen
Journal:  J Nat Prod       Date:  1995-02       Impact factor: 4.050

7.  Structural Elucidation and Biological Activity of a Highly Regular Fucosylated Glycosaminoglycan from the Edible Sea Cucumber Stichopus herrmanni.

Authors:  Xiaomei Li; Lan Luo; Ying Cai; Wenjiao Yang; Lisha Lin; Zi Li; Na Gao; Steven W Purcell; Mingyi Wu; Jinhua Zhao
Journal:  J Agric Food Chem       Date:  2017-10-17       Impact factor: 5.279

8.  α-Synuclein Transgenic Drosophila As a Model of Parkinson's Disease and Related Synucleinopathies.

Authors:  Hideya Mizuno; Nobuhiro Fujikake; Keiji Wada; Yoshitaka Nagai
Journal:  Parkinsons Dis       Date:  2010-12-20

Review 9.  Plant Extracts and Phytochemicals Targeting α-Synuclein Aggregation in Parkinson's Disease Models.

Authors:  Hayate Javed; Mohamed Fizur Nagoor Meeran; Sheikh Azimullah; Abdu Adem; Bassem Sadek; Shreesh Kumar Ojha
Journal:  Front Pharmacol       Date:  2019-03-19       Impact factor: 5.810

10.  Effects of α-synuclein overexpression in transgenic Caenorhabditis elegans strains.

Authors:  Rakesh Bodhicharla; Archana Nagarajan; Jody Winter; Ademola Adenle; Aamir Nazir; Declan Brady; Kelly Vere; Jo Richens; Paul O'Shea; David R Bell; David de Pomerai
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-12       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.